Literature DB >> 15000823

Strategies for generation of an siRNA expression library directed against the human genome.

Makoto Miyagishi1, Kazunari Taira.   

Abstract

RNA interference (RNAi) is a phenomenon whereby expression of an individual gene is specifically silenced by the introduction of a double-stranded RNA (dsRNA) whose sequence is homologous to that of the gene in question. The generation of a small interfering RNA (siRNA) expression library directed against the entire human genome is a project that requires solutions to many difficult technical problems. We present here some strategies for solving some of these problems, including the development of genetically stable and highly active siRNA expression vectors, a procedure for selection of favorable target sites, and an efficient and inexpensive procedure for constructing an siRNA expression library.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15000823     DOI: 10.1089/154545703322617005

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  26 in total

1.  Effects on RNAi of the tight structure, sequence and position of the targeted region.

Authors:  Koichi Yoshinari; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

2.  Control of siRNA expression using the Cre-loxP recombination system.

Authors:  Vivi Kasim; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

3.  Involvement of template-activating factor I/SET in transcription of adenovirus early genes as a positive-acting factor.

Authors:  Hirohito Haruki; Mitsuru Okuwaki; Makoto Miyagishi; Kazunari Taira; Kyosuke Nagata
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Evaluation of BACE1 Silencing in Cellular Models.

Authors:  Malgorzata Sierant; Katarzyna Kubiak; Julia Kazmierczak-Baranska; Masaki Warashina; Tomoko Kuwabara; Barbara Nawrot
Journal:  Int J Alzheimers Dis       Date:  2009-07-14

5.  An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease.

Authors:  Reiko Onuki; Yoshio Bando; Eigo Suyama; Taiichi Katayama; Hiroaki Kawasaki; Tadashi Baba; Masaya Tohyama; Kazunari Taira
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

6.  Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.

Authors:  Lina Zhao; Yanglin Pan; Yi Gang; Honghong Wang; Haifeng Jin; Jun Tie; Lin Xia; Yongguo Zhang; Lijie He; Liping Yao; Taidong Qiao; Tingting Li; Zhiguo Liu; Daiming Fan
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

7.  The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53.

Authors:  Wen-Fang Li; Arin Herkilini; Yu Tang; Ping Huang; Guan-Bin Song; Makoto Miyagishi; Vivi Kasim; Shou-Rong Wu
Journal:  Acta Pharmacol Sin       Date:  2021-02-01       Impact factor: 6.150

8.  Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy.

Authors:  Dongdong Wang; Yasushi Saga; Hiroaki Mizukami; Naoto Sato; Hiroaki Nonaka; Hiroyuki Fujiwara; Yuji Takei; Shizuo Machida; Osamu Takikawa; Keiya Ozawa; Mitsuaki Suzuki
Journal:  Int J Oncol       Date:  2011-12-13       Impact factor: 5.650

9.  Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus.

Authors:  Akihiro Shimizu; Nobuyuki Kobayashi; Kazuya Shimada; Kuniaki Oura; Tadao Tanaka; Aikou Okamoto; Kazuhiro Kondo
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells.

Authors:  Takahiro Koyanagi; Yasushi Saga; Yoshifumi Takahashi; Yasuhiro Suzuki; Mitsuaki Suzuki; Yasufumi Sato
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.